USD 741.2 million
Report ID:
SQMIG35I2208 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
108
|Figures:
76
Global Fetal Bovine Serum Market size was valued at USD 741.2 million in 2023 and is poised to grow from USD 792.27 million in 2024 to USD 1350.11 million by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).
Growing investments in cell research and biopharmaceutical research are projected to primarily drive up the demand for fetal bovine serum over the coming years. Advancements in cell culture technologies and rising demand for regenerative medicine are also expected to bolster fetal bovine serum market growth in the future. Rising incidence of chronic diseases and growing demand for cell therapies for their treatment are also expected to create new opportunities for fetal bovine serum companies in the long run. On the contrary, supply chain constraints, availability of alternatives, and variability in batches are some restraints that are slated to impede the adoption of fetal bovine serum in the future. Ethical concerns about animal testing are estimated to emerge as a key constraint for fetal bovine serum companies going forward.
Market snapshot - 2025-2032
Global Market Size
USD 741.2 million
Largest Segment
Vaccine Production
Fastest Growth
In-vitro Fertilization
Growth Rate
6.9% CAGR
To get more reports on the above market click here to Buy The Report
Global Fetal Bovine Serum Market is segmented by Types, Application, End-User and region. Based on Types, the market is segmented into Charcoal Stripped, Stem Cells, Dialyzed, Inactivated and Others. Based on Application, the market is segmented into Drug Discovery, Cell Culture, Immunoassay and Others. Based on End-User, the market is segmented into Research And Academic Institutions, Diagnostics Labs, Pharmaceuticals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Pharmaceutical and biotechnology companies are projected to be the largest end users of fetal bovine serum around the world. Growing investments in cell research and rising use of fetal bovine serum in drug discovery and development process are expected to aid the dominance of this segment going forward. High emphasis on stem cell and regenerative medicine research is also expected to create new opportunities for fetal bovine serum companies focusing on this segment in the future. Pharmaceutical and biotechnology companies are expected to maintain their high fetal bovine serum market share across the forecast period owing to high demand for pharmaceuticals and biopharmaceuticals.
Meanwhile, the demand for fetal bovine serum in contract research organizations (CROs) is forecasted to rise at an impressive pace in the future. Growing popularity of outsourcing research and development in healthcare is projected to make this segment highly opportune in the long run. Rising healthcare research costs and increasing emphasis on improving efficiency in healthcare R&D process are also expected to promote the demand for fetal bovine serum in CROs over the coming years. The Asia Pacific region is expected to be highly opportune for fetal bovine serum providers targeting this segment owing to the presence of multiple CROs in this region.
Vaccine production is forecasted to account for a major chunk of the global fetal bovine serum market share in the future. Due to fetal bovine serum being rich in growth factors and nutrients it is extensively used in the production of vaccines as it promotes healthy cell growth and better proliferation. Rapidly increasing incidence of chronic and infectious diseases around the world and growing need for vaccines for the same are helping this segment lead the global fetal bovine serum demand outlook. The COVID-19 pandemic is a testament to how important vaccines development and production is when it comes to global diseases management.
On the other hand, the demand for fetal bovine serum for in-vitro fertilization is expected to increase at a notable CAGR over the coming years. The surging popularity of in-vitro fertilization and its increasing adoption around the world are creating new opportunities for fetal bovine serum suppliers going forward. Fetal bovine serum is capable of providing essential nutrients, hormones, and growth factors for healthy embryo development thereby making it a key element in in-vitro fertilization applications. Fetal bovine serum is mostly used in combination with human serum albumin to improve the quality of embryos.
To get detailed analysis on other segments, Request For Free Sample Report
North America is forecasted to account for a high fetal bovine serum market share on a global level. Rising healthcare research and development activity, growing emphasis on improving biopharmaceutical production, and presence of multiple pharmaceutical companies are key factors allowing this region to maintain its dominant stance. The United States is slated to spearhead revenue generation in North America followed by Canada over the coming years. Availability of supportive government funding for medical research and rising investments in stem cell and regenerative medicine research are also slated to create new opportunities for fetal bovine serum providers in this region.
The demand for fetal bovine serum in the Asia Pacific region is slated to increase at an impressive pace across the study period. Growing investments in medical R&D and the presence of key pharmaceutical companies are creating new opportunities for fetal bovine serum suppliers. Rising awareness regarding benefits of cell therapies and the subsequent increase in their demand for treatment of chronic diseases is also expected to bolster the fetal bovine serum market forecast for the Asia-Pacific region through 2031 and beyond. India, Japan, and China are estimated to emerge as leading markets in this region owing to the presence of leading contract research organizations in these countries.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Biopharmaceutical R&D Activity
High Investments in Stem Cell Research
Ethical Concerns Regarding Animal Welfare
Batch Variability Creating Inconsistency
Request Free Customization of this report to help us to meet your business objectives.
Fetal bovine serum providers should focus on solving the ethical concerns surrounding the production of their product to maximize business scope. Targeting countries where investments in cell research are high is expected to offer better returns on investments for fetal bovine serum providers. Fetal bovine serum companies should also try to achieve consistency in different batches of fetal bovine serum to improve consistency of results.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, high investments in cell research and development, and increasing biopharmaceutical research activity are projected to bolster fetal bovine serum market outlook in the future. However, batch variability and ethical concerns regarding sourcing are estimated to hamper fetal bovine serum demand over the coming years. High medical research investments and the presence of leading biopharmaceutical companies allow North America to maintain a dominant share of the global fetal bovine serum industry. Fetal bovine serum companies should focus on integrating their offerings with advanced bioprocessing technologies and target 3D cell culture to maximize their business scope in the long run.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 741.2 million |
Market size value in 2032 | USD 1350.11 million |
Growth Rate | 6.9% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Fetal Bovine Serum Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Fetal Bovine Serum Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Fetal Bovine Serum Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Fetal Bovine Serum Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Fetal Bovine Serum Market size was valued at USD 1.79 Billion in 2023 and is poised to grow from USD 2.04 Billion in 2024 to USD 5.88 Billion by 2032, growing at a CAGR of 14.1% during the forecast period (2025-2032).
Fetal bovine serum providers should focus on solving the ethical concerns surrounding the production of their product to maximize business scope. Targeting countries where investments in cell research are high is expected to offer better returns on investments for fetal bovine serum providers. Fetal bovine serum companies should also try to achieve consistency in different batches of fetal bovine serum to improve consistency of results. 'Thermo Fisher Scientific Inc. (US)', 'Merck KGaA (Germany)', 'GE Healthcare (US)', 'Tissue Culture Biologicals (US)', 'HiMedia Laboratories Pvt. Ltd. (India)', 'Atlanta Biologicals Inc. (US)', 'Sigma-Aldrich Corporation (US)', 'Rocky Mountain Biologicals (US)', 'PAN-Biotech GmbH (Germany)', 'Bovogen Biologicals Pty Ltd. (Australia)', 'Biowest SAS (France)', 'Biological Industries Israel Beit Haemek Ltd. (Israel)', 'Corning Incorporated (US)', 'Sera Laboratories International Ltd. (UK)', 'Caisson Laboratories Inc. (US)', 'Hyclone Laboratories Inc. (US)', 'Lanzhou Minhai Biotechnology Co., Ltd. (China)', 'Moregate BioTech (UK)', 'Gemini Bio-Products (US)', 'Lampire Biological Laboratories (US)'
Surging use of monoclonal antibodies, vaccines, and cell therapies for the treatment of various diseases has resulted in high demand for biopharmaceutical research around the world. Fetal bovine serum is a key supplement in cell culture media required for biopharmaceutical production thereby making this a key fetal bovine serum market growth driver.
Use in 3D Cell Culture: Investments in 3D cell culture are increasing rapidly around the world and this is expected to present new opportunities for fetal bovine serum providers in the future. Fetal bovine serum can play a vital role in maintaining stability of complex 3D cell culture systems over the coming years and boost revenue generation potential for market players.
North America is forecasted to account for a high fetal bovine serum market share on a global level. Rising healthcare research and development activity, growing emphasis on improving biopharmaceutical production, and presence of multiple pharmaceutical companies are key factors allowing this region to maintain its dominant stance. The United States is slated to spearhead revenue generation in North America followed by Canada over the coming years. Availability of supportive government funding for medical research and rising investments in stem cell and regenerative medicine research are also slated to create new opportunities for fetal bovine serum providers in this region.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35I2208
sales@skyquestt.com
USA +1 351-333-4748